Animal Biotechnology Market Analysis North America, Europe, APAC, Rest of World (ROW) - US, Canada, China, Germany, UK - Size and Forecast 2024-2028

Animal Biotechnology Market 2024-2028

The global animal biotechnology market size is estimated to grow by USD 3.65 billion at a CAGR of 3.01% between 2023 and 2028. 

Companies in the global animal biotechnology market are increasingly focusing on strategic developments, such as product enhancements and innovations, to extend their product portfolios. This will ensure the availability of drugs, vaccines, and diagnostic tests for the detection, treatment, and prevention of infectious and parasitic diseases in animals. The key strategies adopted include the launch of new products, product approvals, joint ventures, acquisitions, partnerships, expansion projects, collaborations, and investments. For instance, in February 2021, Merck Animal Health, a division of Merck & Co., Inc., announced the acquisition of Poultry Sense Ltd., a provider of enhanced technology for poultry farmers to track and analyze health performance for the life of the flock. The technology can detect health conditions earlier in poultry that can lead to illness, thus reducing the potential for disease outbreaks. Therefore, the growing number of product developments and collaborations undertaken by the vendors in the market is expected to drive the growth of the animal biotechnology market during the forecast period.

Technavio has segmented the market into product, animal type, and geography 

• The product  segment is classified into drugs, vaccines, diagnostic tests, and others
• The animal type segment is classified into livestock/production and companion
• The geography segment includes key regions such as North America, Europe, APAC, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018 - 2022, besides analyzing the current market scenario.

What will be the Size of the Animal Biotechnology Market During the Forecast Period?

To learn more about this report, Request Free Sample

Animal Biotechnology Market Segmentation by Product, Animal Type and Geography Analysis

Product Analysis 

Drugs

The market share growth by the drugs segment will be significant during the forecast period.  Drugs are used to treat animal diseases such as foot and mouth disease (FMD), salmonella, swine fever, avian influenza, and bovine respiratory disease (BRD). The manufacturing, placing on the market, and use of animal drugs are regulated by the European Medicines Agency (EMA) Veterinary Medicines Division and the US Food and Drug Administration (FDA).

Get a glance at the market contribution of various segments Download PDF Sample

The drugs segment was the largest and was valued at USD 6.52 billion in 2018. The main types of drugs that are currently available for the treatment of animals include antibiotics, antiparasitic, and pain-relieving medications. Antiparasitic drugs can be used to treat commonly occurring bacterial diseases in animals raised on farms, such as respiratory and gastrointestinal infections. These drugs can be used to control internal and external parasites in poultry flocks, sheep and cattle, and pig herds. The company Zolvix Plus is used for the treatment of sensitive nematodes (roundworms). The drug can also be used for the treatment and control of gastrointestinal nematode parasites of sheep, such as Haemonchus contortus and Teladorsagia circumcincta.  The usage of drugs to treat a wide range of animal diseases will lead to the growth of the market segment during the forecast period.

Animal Type Analysis 

Livestock/production

Livestock plays a crucial economic and socio-cultural role, especially in rural households, as it provides income, food supply, asset saving, employment, and livelihood. It also helps retain soil fertility and maintain agricultural traction diversification and sustainable agricultural production. Livestock production is closely interrelated with crop production. In many countries, policies related to livestock are often incoherent, with little assessment of their possible impact. The lack of integrated and consistent strategies focusing limited resources on attainable goals is a major constraint to livestock development. As infectious diseases are highly prevalent in livestock, immunodiagnostics and molecular diagnostic test kits and reagents are anticipated to register significant demand in the livestock/production animal market, which in turn will boost the growth of the global animal biotechnology market during the forecast period.

Companion

The majority of pet lovers prefer dogs and cats to other pets. It is estimated that over three-fifths of households in the US have one or more companion animals. These animals play an important part in the lives of their owners. Apart from providing companionship, they also provide a sense of responsibility to the owners. Studies have linked pet ownership to reduced stress, low blood pressure, and low incidence of heart disease. The rising social acceptance of pets has led to public spaces becoming pet-friendly. Factors such as the rising awareness of the importance of companion animals, the importance of vaccination, and diagnostics tests are providing information for owners on preventing their pets from getting disease. Pets are an important part of the emotional quotient of many people. It is, therefore, important to take care of companion animals and protect them from harm. Thus, the importance of pets in the lives of their owners prompts them to spend on animal healthcare, thus driving the growth of the segment and,

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 47% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America accounted for the largest revenue share of the global animal biotechnology market in 2023. The US and Canada accounted for the highest market shares in the region during the same year. The growth of the market can be attributed to rising pet adoption, increasing awareness regarding animal healthcare, advanced veterinary healthcare infrastructure in the region, increasing demand for animal-based products, and the presence of prominent vendors in the region. Additionally, there is the presence of various animal welfare associations in the region that work on improving animal welfare and spreading awareness about national veterinary issues.

For instance, the Canadian Veterinary Medical Association (CVMA) and American Veterinary Medical Association (AVMA) conduct various campaigns to promote animal health. These initiatives will positively influence the regional market and will boost the demand for animal biotechnology products during the forecast period.

COVID Recovery Analysis

In 2020, the COVID-19 pandemic had a negative impact on the regional animal biotechnology market. However, in H2 2020, due to the availability of vaccines, the number of COVID-19 cases in the region declined. Thus, with access to veterinary clinics, the demand for animal biotechnology products rebounded. For instance, IDEXX Laboratories reported that the demand for the company's companion animal products rebounded in H2 2020 due to an increase in pet ownership and higher levels of diagnostic test frequency. Thus, due to these factors, the regional animal biotechnology market will continue to witness growth during the forecast period.

Buy Full Report Now

Key Animal Biotechnology Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Bayer AG - The company offers animal biotechnology such as animal disease treatment through Bayer Animal Pharmaceuticals.

• Anicell BioTech
• Bayer AG
• Biogenesis Bago SA
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Inc.
• EW Group GmBH
• Genus Plc
• Heska Corp.
• Hester Biosciences Ltd.
• IDEXX Laboratories Inc.
• Ivaoes LLC
• Merck and Co. Inc.
• Neogen Corp.
• Pfizer Inc.
• Randox Laboratories Ltd.
• Santa Cruz Biotechnology Inc.
• Vimian Group AB
• Virbac Group
• Z Link Biotech Co. Ltd.
• Zeus Biotech Pvt. Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Animal Biotechnology Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. 

Key Animal Biotechnology Market Drivers

The use of transgenic animals to produce recombinant proteins is notably driving the market growth. Transgenic animals are referred to as those whose genome has changed to carry genes from another species. Transgenesis is a process or technique that involves the introduction of foreign DNA sequences into the genome of transfected cells. This is done to achieve a higher growth rate, improvement in feed utilization, increased resistance to disease, and many more. This has been introduced into the majority of the animal's food, such as cattle, sheep, goats, chickens, cats, rats, and others.

Moreover, transgenic animals are required in many fields, such as agricultural techniques and food supply development, to address the demand in the current and future of the human race, as they can also play a vital role in pharmaceuticals to treat human illness and many more. Hence, the use of transgenic animals plays a vital role in the global animal biotechnology market during the forecast period.

Significant Animal Biotechnology Market Trends

Advancements in R&D for animal biotechnology are an emerging trend shaping the market growth. Innovations and advancements in genetic engineering and immunology have enhanced the growth of animal biotechnology. The R&D expenditure is primarily driven by factors such as the increase in chronic diseases, the ageing population, global population growth, and growing life expectancy. These factors are positively influencing the demand for animal biotechnology in life sciences research. For instance, in March 2022, Inbio, a biotech company that has partnered with Bayer A G, which is a Europe-based company, tackled the mammalian allergy where the domestic cat was the source that affected children and adults. Although it had some exceptionally common treatments, such as antihistamines, were limited, they introduced a technology called CRISPR, which was the first treatment to effectively remove cat allergen from the source.

However, such advancements and research institutes largely depend on the financial assistance provided by governments and other private organizations to procure necessary products. Various government bodies are also making efforts to increase R&D investments in the healthcare sector. Thus, various R&D advancements in animal biotechnology and investments and initiatives are anticipated to drive the growth of the global animal biotechnology market during the forecast period.

Major Animal Biotechnology Market Challenges

The lack of a skilled workforce to perform diagnostic tests is a significant challenge hindering the market growth. Veterinary diagnostics require skilled professionals to perform accurate testing for inherited diseases and traits in companion animals and livestock, as well as farmed poultry, captive species, and wildlife. The lack of highly skilled professionals with clinical and analytical knowledge to perform and interpret polymerase chain reaction (PCR) assay designs, deoxyribonucleic acid (DNA)-based diagnostic assays, and understand the application of veterinary diagnostics and their impact on the management of different animal groups impact the adoption and use of veterinary diagnostic tests.

However, the decrease in the number of educational programs offered to students on veterinary diagnostic techniques, inadequate facilities in healthcare centers, and lack of availability of modern diagnostic laboratories in emerging economies led to a lack of awareness about veterinary diagnostic tests. These factors will negatively impact the growth of the global animal biotechnology market during the forecast period.

Buy Full Report Now

Key Animal Biotechnology Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Animal Biotechnology Market Customer Landscape

Segment Overview

The animal biotechnology market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

• Product Outlook
  • Drugs
  • Vaccines
  • Diagnostic tests
  • Others

• Animal Type Outlook
  • Livestock/production
  • Companion

• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest Of World
    • Brazil
    • Argentina 
    • Australia

Animal Biotechnology Market Scope
Report Coverage	Details
Page number	171
Base year	2023
Historic period	2018 - 2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 3.01%
Market Growth 2024-2028	USD 3.65 billion
Market structure	Fragmented
YoY growth 2023-2024(%)	2.82
Regional analysis	North America, Europe, APAC, and Rest of World (ROW)
Performing market contribution	North America at 47%
Key countries	US, Canada, China, Germany, and UK
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	Anicell BioTech, Bayer AG, Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., EW Group GmBH, Genus Plc, Heska Corp., Hester Biosciences Ltd., IDEXX Laboratories Inc., Ivaoes LLC, Merck and Co. Inc., Neogen Corp., Pfizer Inc., Randox Laboratories Ltd., Santa Cruz Biotechnology Inc., Vimian Group AB, Virbac Group, Z Link Biotech Co. Ltd., and Zeus Biotech Pvt. Ltd.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Animal Biotechnology Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the animal biotechnology market between 2024 and 2028
• Precise estimation of the animal biotechnology market size and its contribution of the market in focus to the parent market
• Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
• Companies landscape comparing criticality of inputs and factors of differentiation
• Exclusive Matrix on companies position and classification
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the market across North America, Europe, APAC, and Rest of World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of animal biotechnology market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch